Aurisco Pharmaceutical Co.,Ltd.

SHSE:605116 Voorraadrapport

Marktkapitalisatie: CN¥9.0b

Aurisco PharmaceuticalLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Aurisco PharmaceuticalLtd has a total shareholder equity of CN¥2.3B and total debt of CN¥847.3M, which brings its debt-to-equity ratio to 37.4%. Its total assets and total liabilities are CN¥3.7B and CN¥1.4B respectively. Aurisco PharmaceuticalLtd's EBIT is CN¥365.7M making its interest coverage ratio -18.1. It has cash and short-term investments of CN¥1.1B.

Belangrijke informatie

37.4%

Verhouding schuld/eigen vermogen

CN¥847.28m

Schuld

Rente dekkingsratio-18.1x
ContantCN¥1.13b
AandelenCN¥2.27b
Totaal verplichtingenCN¥1.42b
Totaal activaCN¥3.69b

Recente financiële gezondheidsupdates

Recent updates

Is Aurisco PharmaceuticalLtd (SHSE:605116) A Risky Investment?

Sep 19
Is Aurisco PharmaceuticalLtd (SHSE:605116) A Risky Investment?

Is Now The Time To Put Aurisco PharmaceuticalLtd (SHSE:605116) On Your Watchlist?

Aug 14
Is Now The Time To Put Aurisco PharmaceuticalLtd (SHSE:605116) On Your Watchlist?

Investors Interested In Aurisco Pharmaceutical Co.,Ltd.'s (SHSE:605116) Earnings

Jun 28
Investors Interested In Aurisco Pharmaceutical Co.,Ltd.'s (SHSE:605116) Earnings

Aurisco PharmaceuticalLtd (SHSE:605116) Has A Pretty Healthy Balance Sheet

Jun 07
Aurisco PharmaceuticalLtd (SHSE:605116) Has A Pretty Healthy Balance Sheet

Investors Shouldn't Be Too Comfortable With Aurisco PharmaceuticalLtd's (SHSE:605116) Earnings

May 12
Investors Shouldn't Be Too Comfortable With Aurisco PharmaceuticalLtd's (SHSE:605116) Earnings

Here's Why We Think Aurisco PharmaceuticalLtd (SHSE:605116) Might Deserve Your Attention Today

Apr 22
Here's Why We Think Aurisco PharmaceuticalLtd (SHSE:605116) Might Deserve Your Attention Today

Analyse van de financiële positie

Kortlopende schulden: 605116's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥537.8M).

Langlopende schulden: 605116's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥884.9M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 605116 has more cash than its total debt.

Schuld verminderen: 605116's debt to equity ratio has increased from 0% to 37.4% over the past 5 years.

Schuldendekking: 605116's debt is well covered by operating cash flow (47%).

Rentedekking: 605116 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven